NovaDel Pharma Inc.
Pharma company reports financial results
Published in Lab Business Week, January 16th, 2005
The net loss for the period was $2.3 million, or 7 cents per share, compared to a net loss of $1.0 million, or 6 cents per share, in the year-ago period. The larger net loss is due to increased spending for research and development, general administrative expenses including depreciation of recently purchased equipment to enhance formulation efforts, and consulting fees. Cash, cash equivalents and investment securities at October 31, 2004 stood at $9.8 million compared to $9.7 million at July 31, 2004.
The quarter's...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2005-01-16)
More Articles from Lab Business Week
- Alexion Pharmaceuticals, Inc.
Pharmaceutical firm reports loss of $1.01 per share - Amphora Discovery Corporation
Drug discovery company completes $20M Series C financing - Array BioPharma, Inc.
Biopharma company prices public offering of 8,000,000 shares of common stock - Arrowhead Research Corporation
Company provides additional funding for nanotech research - Bentley Pharmaceuticals, Inc.
Pharmaceutical firm retains investor relations counsel - Biomira, Inc.
Biomira announces U.S. $10 million financing - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
